The state of New York said it will prioritize non-White people in the distribution of COVID-19 treatments in short supply.
New York’s Department of Health released a document detailing its plan to distribute the treatments, such as monoclonal antibody treatment and antiviral pills.
The plan includes a section on eligibility for the scarce antiviral pills that people must meet to receive the treatment, including a line stating a person needs to have “a medical condition or other factors that increase their risk for severe illness.”
One such “risk factor” is being a race or ethnicity that is not White due to “longstanding systemic health and social inequities”
“Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19,” the memo reads.